Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Kelly

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
The Journal of Pathology. Clinical Research|September 12, 2023
Accounting for intensity variation in image analysis of large-scale multiplexed clinical trial datasetsAnja L Frei, Anthony McGuigan, Ritik Rak Sinha, et al.
The Lancet. Oncology|February 1, 2024
Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II-III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysisAnja L Frei, Anthony McGuigan, Ritik R A K Sinha, et al.
JAMA Surgery|June 12, 2024
Time From Colorectal Cancer Surgery to Adjuvant Chemotherapy: Post Hoc Analysis of the SCOT Randomized Clinical TrialMikail Gögenur, Andreas Weinberger Rosen, Timothy Iveson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2026
Three Versus 6 Months of Adjuvant Oxaliplatin-Fluoropyrimidine Chemotherapy for Colorectal Cancer: Final Results of SCOT-An International, Randomized, Phase III, Noninferiority TrialTimothy Iveson, Mark P Saunders, Caroline Kelly, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 11, 2021
Serum Proteomics and Plasma Fibulin-3 in Differentiation of Mesothelioma From Asbestos-Exposed Controls and Patients With Other Pleural DiseasesSelina Tsim, Laura Alexander, Caroline Kelly, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 29, 2024
JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumorsKathryn A F Pennel, Phimmada Hatthakarnkul, Colin S Wood, et al.
BMJ Open Respiratory Research|July 1, 2026
Protocol for Mesothelioma Observational study of Risk prediction and Generation of paired benign-meso tissue samples, Including a Nested MRI Substudy (Meso-ORIGINS)Mark D J Neilly, Alexandrea MacPherson, Laura Alexander, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
The Journal of Pathology. Clinical Research|September 12, 2023
Accounting for intensity variation in image analysis of large-scale multiplexed clinical trial datasetsAnja L Frei, Anthony McGuigan, Ritik Rak Sinha, et al.
The Lancet. Oncology|February 1, 2024
Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II-III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysisAnja L Frei, Anthony McGuigan, Ritik R A K Sinha, et al.
JAMA Surgery|June 12, 2024
Time From Colorectal Cancer Surgery to Adjuvant Chemotherapy: Post Hoc Analysis of the SCOT Randomized Clinical TrialMikail Gögenur, Andreas Weinberger Rosen, Timothy Iveson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2026
Three Versus 6 Months of Adjuvant Oxaliplatin-Fluoropyrimidine Chemotherapy for Colorectal Cancer: Final Results of SCOT-An International, Randomized, Phase III, Noninferiority TrialTimothy Iveson, Mark P Saunders, Caroline Kelly, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 11, 2021
Serum Proteomics and Plasma Fibulin-3 in Differentiation of Mesothelioma From Asbestos-Exposed Controls and Patients With Other Pleural DiseasesSelina Tsim, Laura Alexander, Caroline Kelly, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 29, 2024
JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumorsKathryn A F Pennel, Phimmada Hatthakarnkul, Colin S Wood, et al.
BMJ Open Respiratory Research|July 1, 2026
Protocol for Mesothelioma Observational study of Risk prediction and Generation of paired benign-meso tissue samples, Including a Nested MRI Substudy (Meso-ORIGINS)Mark D J Neilly, Alexandrea MacPherson, Laura Alexander, et al.
Pageof 5